Edgewise Therapeutics, Inc. · NASDAQ:EWTX
Derakhshan Behrad sold 5,100 Edgewise Therapeutics, Inc. shares (Form 4)
Traded Aug 12, 2026 · Filed Aug 14, 2026
On Aug 12, 2026, Derakhshan Behrad (Chief Business Officer) sold 5,100 Edgewise Therapeutics, Inc. shares at an average US$43.81 for US$223K, leaving 31,826 shares. Filed Aug 14, 2026 (Form 4).
- Sold
- 5,100 shares
- Price
- US$43.81 average (US$43.70 to US$44.50)
- Value
- US$223K
- Holding after
- 31,826 shares
- Trading plan
- No
- Role
- Chief Business Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Aug 12, 2026 | Common Stock | Option exercise | 5,781 | 29,426 | Direct | |
| Aug 12, 2026 | Common Stock | Option exercise | 7,500 | 36,926 | Direct | |
| Aug 12, 2026 | Common Stock | Sale | 2,171 | US$43.79 | 34,755 | Direct |
| Aug 12, 2026 | Common Stock | Sale | 304 | US$44.50 | 34,451 | Direct |
| Aug 12, 2026 | Common Stock | Sale | 150 | US$44.44 | 34,301 | Direct |
| Aug 12, 2026 | Common Stock | Sale | 2,475 | US$43.70 | 31,826 | Direct |